Expansion of Asia sales in the pharmaceutical business and higher revenue but lower profit
First written in FY2018-Q1. 12 of 31 entries say "Advanced", first in FY2018-Q2. Latest entry: 2026-08-07.
The whole theme swung hardest in 2022: 3 of 7 companies on the "Worse" side.
2 other companies' latest entry also says "Mitigated".
- 2026-08-07MitigatedEarnings
「Although raw material prices increased and personnel expenses, depreciation and transportation costs also rose, operating income increased as the effect of higher revenue outweighed these factors.」
In the chemicals business, operating income increased 16.9% year on year due to the effect of higher revenue, despite continued increases in raw material prices, personnel expenses and other costs. - FY2026Revenue growth and profit declineAnnual report
「The Chemicals Business recorded revenue of ¥5,891.9 million, up 2.3% year on year, and operating profit of ¥936.3 million, down 9.4%.」
The Chemicals Business recorded higher revenue as sales increased, particularly in Asia, while profit declined due to increases in raw material prices, personnel expenses and depreciation. - FY2026-H1Revenue growth and profit declineAnnual report
「Revenue was ¥2,882.7 million, up 1.8% year on year, and operating profit was ¥449.3 million, down 11.7%. In Japan, sales volumes, led by the steel sector, were slightly above the same period of the previous year and remained on a gradual recovery trend. In addition, increased sales of high-value-added products in Japan and overseas contributed to higher revenue for the Chemicals Business as a whole. On the profit side, operating profit declined due to raw material prices remaining at elevated levels and increases in personnel expenses and depreciation.」
The Chemicals Business recorded a 1.8% increase in revenue due to higher sales of high-value-added products and other factors, while operating profit declined 11.7% due to increases in raw material prices, personnel expenses and depreciation. - FY2025AdvancedAnnual report
「Revenue was ¥5,761.6 million, up 2.4% year on year, and operating profit was ¥1,034.0 million, up 2.8%.」
The Chemicals Business recorded higher revenue and profit due to high-value-added products, expanded sales in China and India, the weaker yen and higher revenue. - FY2025-H1AdvancedAnnual report
「Revenue was ¥2,831.3 million, up 2.8% year on year, and operating profit was ¥508.7 million, up 10.9%.」
The Chemicals Business recorded a 2.8% increase in revenue and a 10.9% increase in operating profit. Higher sales of high-value-added products, expanded sales in India, the weaker yen and higher revenue contributed to the results. - FY2024AdvancedAnnual report
「Revenue was ¥5,626.9 million, up 6.3% year on year, and operating profit was ¥1,006.2 million, up 31.1%.」
The Chemicals Business recorded a 6.3% increase in revenue and a 31.1% increase in operating profit. The recovery of production by major domestic customers, higher selling prices, and expanded sales in India and Indonesia contributed to the results. - FY2024-Q3AdvancedAnnual report
「Revenue was ¥4,236.3 million, up 7.0% year on year, and operating profit was ¥758.3 million, up 31.9%.」
The Chemicals Business recorded a 7.0% increase in revenue and a 31.9% increase in operating profit. The recovery of production by major domestic customers, higher selling prices, and expanded sales in India and Indonesia contributed to the results. - FY2024-Q2AdvancedAnnual report
「Revenue was ¥2,753.2 million, up 7.6% year on year, and operating profit was ¥458.6 million, up 24.4%. …In addition, higher selling prices in Japan and overseas and expanded sales in India and Indonesia contributed to higher revenue for the Chemicals Business as a whole.」
The Chemicals Business recorded higher revenue and profit due to higher selling prices, expanded sales in India and Indonesia, and the recovery of production by major domestic customers. - FY2024-Q1AdvancedAnnual report
「Revenue was ¥1,341.4 million, up 8.6% year on year, and operating profit was ¥213.4 million, up 18.3%.」
The Chemicals Business recorded higher revenue and profit due to the recovery of production by major domestic customers, higher selling prices and expanded sales in India. - FY2023Higher sales and modest profit growthAnnual report
「Revenue was ¥5,291.1 million, up 13.5% year on year, and operating profit was ¥767.2 million, up 0.2%.」
The Chemicals Business recorded higher revenue due to higher selling prices and the recovery of sales in Asia, including India and Indonesia, but profit growth was limited due to higher raw material prices. - FY2023-Q3Continued revenue growth and profit declineAnnual report
「Revenue was ¥3,957.7 million, up 13.9% year on year, and operating profit was ¥575.1 million, down 8.0%. …In addition, higher selling prices in Japan and overseas and the recovery of sales in Asia, including India and Indonesia, contributed to higher revenue for the Chemicals Business as a whole. However, profitability declined because raw material prices remained elevated and sales volumes, although recovering, had not reached the previous year's level, resulting in lower operating profit.」
The Chemicals Business recorded a 13.9% increase in revenue due to higher selling prices and the recovery of sales in Asia, including India and Indonesia, while operating profit declined 8.0% due to higher raw material prices and sales volumes remaining below the previous year's level. - FY2023-Q2Continued revenue growth and profit declineAnnual report
「Revenue was ¥2,558.6 million, up 10.0% year on year, and operating profit was ¥368.7 million, down 15.9%. In Japan, sales of metal surface treatment agents remained sluggish due to the impact of production cuts by major customers that had continued since the second half of the previous fiscal year. However, the recovery of sales in Asia, including India and Indonesia, contributed to higher revenue for the Chemicals Business as a whole. Profitability declined due to soaring raw material prices and lower domestic sales volumes, resulting in lower operating profit.」
The Chemicals Business recorded a 10.0% increase in revenue due to the recovery of sales in Asia, including India and Indonesia, while operating profit declined 15.9% due to higher raw material prices and lower domestic sales volumes. - FY2023-Q1Revenue growth and profit declineAnnual report
「Revenue was ¥1,235.5 million, up 6.4% year on year, and operating profit was ¥180.4 million, down 20.5%.」
The Chemicals Business recorded higher revenue as sales recovered in Asian markets, including India, South Korea and Indonesia, while profit declined due to higher raw material prices and lower domestic sales volumes. - FY2022AdvancedAnnual report
「Revenue from external customers was ¥4,663.1 million, up 14.8% year on year, and operating profit was ¥765.6 million, up 20.0%.」
The Chemicals Business recorded higher revenue and profit due to the recovery of sales in Japan and across Asia, including China, Thailand, Indonesia and India. - FY2022-Q3AdvancedAnnual report
「Revenue was ¥3,474.9 million, up 19.0% year on year, and operating profit was ¥625.4 million, up 39.1%. Although major customers in Japan and overseas adjusted production due to factors including semiconductor shortages, the recovery trend in Japan that began in the previous fiscal year continued, and sales of metal surface treatment agents remained firm. Overseas, sales recovered strongly in Asia, including Thailand, Indonesia, China and South Korea, resulting in higher revenue and profit.」
The Chemicals Business recorded a 19.0% increase in revenue and a 39.1% increase in operating profit due to the recovery trend in Japan and the recovery of sales in Asia, including Thailand, Indonesia, China and South Korea. - FY2022-Q2AdvancedAnnual report
「Revenue was ¥2,326.8 million, up 27.8% year on year, and operating profit was ¥438.4 million, up 87.9%. In Japan, the recovery trend that began in the second half of the previous year continued, and sales of metal surface treatment agents remained firm. Overseas, sales recovered strongly in Asia, including Thailand, China, India, South Korea and Indonesia, resulting in higher revenue and profit.」
The Chemicals Business recorded a 27.8% increase in revenue and an 87.9% increase in operating profit due to the recovery trend in Japan and the recovery of sales in Asia. - FY2022-Q1AdvancedAnnual report
「Revenue was ¥1,161.7 million, up 26.5% year on year, and operating profit was ¥227.0 million, up 94.7%. In Japan, the recovery trend that began in the second half of the previous year continued, and sales of metal surface treatment agents remained firm. Overseas, sales in Asia, particularly in China and Thailand, showed a clear recovery, resulting in higher revenue and profit.」
The Chemicals Business recorded a 26.5% increase in revenue and a 94.7% increase in operating profit due to the recovery trend in Japan and the recovery of sales in Asia, particularly in China and Thailand. - FY2021-Q3Revenue and profit continued to decline, but production improved this quarter.Annual report
「Revenue was ¥2,919.4 million, down 16.1% year on year, and operating profit was ¥449.5 million, down 22.3%. Due to the impact of the COVID-19 pandemic, customers in Japan, including those in the steel and automotive industries, implemented production cuts and adjustments, while overseas operations faced difficult conditions, including being forced to shut down factories at the request of governments. During the third quarter of the fiscal year, production improved among customers in the steel and automotive industries, but revenue and operating profit still declined.」
The Chemicals Business recorded a 16.1% decrease in revenue and a 22.3% decrease in operating profit on a cumulative basis. Although customers' production improved, cumulative results continued to show declines in both revenue and profit. - FY2021-Q2Revenue and profit continued to declineAnnual report
「Revenue was ¥1,820 million, down 21.7% year on year, and operating profit was ¥233 million, down 38.9%. Due to the impact of the COVID-19 pandemic, customers in Japan, including those in the steel and automotive industries, implemented production cuts and adjustments, while overseas operations faced difficult conditions, including being forced to shut down factories at the request of governments.」
The Chemicals Business recorded a 21.7% decrease in revenue and a 38.9% decrease in operating profit due to production cuts and adjustments by domestic customers and shutdowns of overseas factories. - FY2021-Q1Lower revenue and profit continuedAnnual report
「Revenue was ¥918.6 million, down 22.3% year on year, and operating profit was ¥116.6 million, down 42.5%. Due to the impact of the COVID-19 pandemic, customers, mainly in Japan's steel and automotive industries, implemented production cuts and adjustments, resulting in substantial declines in both revenue and profit.」
The Chemicals Business recorded a 22.3% decrease in revenue and a 42.5% decrease in operating profit due to production cuts and adjustments by domestic customers, including those in the steel and automotive industries. - FY2020Lower revenue and profit continuedAnnual report
「Overseas demand also remained sluggish, and revenue declined across Asian countries, including Thailand and China. Overall, the Chemicals Business recorded lower revenue and operating profit.」
The Chemicals Business recorded revenue of ¥44,854 million and operating profit of ¥7,546 million, continuing to experience declines in both revenue and profit due to lower domestic automobile production and sluggish overseas demand across Asia. - FY2020-Q3Shifted to lower sales and lower earningsAnnual report
「Revenue was ¥3,389.9 million, down 5.5% year on year, and operating profit was ¥581.4 million, down 12.3%. In Japan, sales of metal surface treatment agents declined, partly because automobile production by our customers fell due to the consumption tax increase and typhoons. Overseas demand also remained sluggish, with revenue declining across Asian countries, including Thailand and China. Overall, the Chemicals Business recorded lower revenue and operating profit.」
The Chemicals Business recorded a 5.5% decrease in revenue and a 12.3% decrease in operating profit due to lower domestic automobile production and sluggish overseas demand across Asia. - FY2020-Q2Lower revenue and profit continuedAnnual report
「Sales were ¥22,666 million, down 2.8% year on year, and operating profit was ¥3,761 million, down 5.1% year on year. ... Overseas demand declined, with sales falling across Asia, including Thailand and China. The Chemicals segment overall therefore posted lower sales and profit.」
Overseas demand across Asia declined, resulting in a 2.8% decrease in revenue and a 5.1% decrease in operating profit in the Chemicals Business. - FY2020-Q1Shifted to lower sales and lower earningsAnnual report
「Sales were ¥11,564 million, down 0.4% year on year, and operating profit was ¥2,021 million, down 2.1% year on year. ... Overseas demand lacked momentum, with sales declining in Asia, including Thailand and China, except in Europe and the United States. The Chemicals segment overall therefore posted lower sales and profit.」
Domestic demand remained firm, but overseas demand in Asia, including Thailand and China, was weak. The Chemicals segment posted a 0.4% decrease in sales and a 2.1% decrease in operating profit. - FY2019Revenue growth but lower profitAnnual report
「Sales to external customers were ¥47,658 million, up ¥2,058 million (4.5%) from the previous fiscal year. Operating profit was ¥8,581 million, down ¥883 million (9.3%).」
The Chemicals segment posted higher sales because of the increase in domestic subsidiaries, but profit declined because of soaring raw material costs and integration costs related to the absorption-type merger. - FY2019-Q3Higher sales and lower profits continued, and the decline in profits widenedAnnual report
「Sales to external customers were ¥35,882 million, up ¥1,519 million (4.4%) from the previous fiscal year. Operating profit was ¥6,629 million, down ¥789 million (10.6%). Sales of metal surface treatment agents remained sluggish, but sales increased in Japan because of the addition of consolidated subsidiaries. Profit declined because of soaring raw material costs and integration costs related to the absorption-type merger of a domestic subsidiary.」
The Chemicals segment posted a 4.4% increase in sales, while operating profit declined 10.6%. Sluggish sales, soaring raw material costs, and integration costs related to the absorption-type merger were cited as factors behind the decline in profit. - FY2019-Q2Higher sales and lower profits continued, and the decline in profits widenedAnnual report
「Sales to external customers were ¥23,328 million, up ¥938 million (4.2%) from the previous fiscal year. Operating profit was ¥3,964 million, down ¥629 million (13.7%). Sales increased in Japan because of the addition of consolidated subsidiaries, while sales of metal surface treatment agents in Thailand remained steady. Profit declined because of soaring raw material costs and integration costs related to the absorption-type merger of a domestic subsidiary.」
The Chemicals segment posted a 4.2% increase in sales, while operating profit declined 13.7%. Soaring raw material costs and integration costs related to the absorption-type merger continued to weigh on profit. - FY2019-Q1Revenue growth but lower profitAnnual report
「Sales to external customers were ¥11,611 million, up ¥343 million (3.1%) from the previous fiscal year. Operating profit was ¥2,065 million, down ¥303 million (12.8%). Sales increased in Japan because of the addition of consolidated subsidiaries, while sales of metal surface treatment agents in Thailand remained steady.」
The Chemicals segment posted higher sales, supported by the increase in consolidated subsidiaries in Japan and steady sales in Thailand, but profit declined because of higher raw material prices and integration costs related to the absorption-type merger. - FY2018-Q3AdvancedAnnual report
「Sales to external customers were ¥34,363 million, up ¥2,059 million (6.4%) from the previous fiscal year. Operating profit was ¥7,418 million, up ¥574 million (8.4%). In Japan, sales of metal surface treatment agents remained relatively steady, supported by the recovery in automobile production and higher steel demand. Overseas sales expanded in Asia, including China, Thailand, and India, although the United States remained sluggish, and operating profit also increased.」
The Chemicals segment posted a 6.4% increase in sales and an 8.4% increase in operating profit, expanding sales in China, Thailand, India, and elsewhere in Asia. - FY2018-Q2AdvancedAnnual report
「Sales to external customers were ¥22,389 million, up ¥1,114 million (5.2%) from the previous fiscal year. Operating profit was ¥4,594 million, up ¥150 million (3.4%). In Japan, sales of metal surface treatment agents and rust-preventive oils remained relatively steady, supported by the recovery in automobile production and higher steel demand associated with construction demand. Overseas sales expanded in Asia, including China and India, but operating profit growth remained sluggish in Japan because profitability declined.」
The Chemicals segment expanded sales in Asia, including China and India, posting a 5.2% increase in sales and a 3.4% increase in operating profit. - FY2018-Q1First statedAnnual report
「Overseas sales expanded in Asia, including China, Thailand, and South Korea, and remained relatively steady. Profitability declined both in Japan and overseas, resulting in higher sales but lower profit overall.」
The Chemicals segment expanded sales in Asia, but lower profitability in Japan and overseas resulted in higher sales but lower profit overall.